3.23
Health Catalyst Inc stock is traded at $3.23, with a volume of 472.38K.
It is down -1.52% in the last 24 hours and up +13.33% over the past month.
Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platforms, analytics applications, and support services. This generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.
See More
Previous Close:
$3.28
Open:
$3.26
24h Volume:
472.38K
Relative Volume:
0.64
Market Cap:
$227.31M
Revenue:
$299.48M
Net Income/Loss:
$-86.45M
P/E Ratio:
-2.1533
EPS:
-1.5
Net Cash Flow:
$-17.32M
1W Performance:
-0.31%
1M Performance:
+13.33%
6M Performance:
-18.23%
1Y Performance:
-58.43%
Health Catalyst Inc Stock (HCAT) Company Profile
Name
Health Catalyst Inc
Sector
Industry
Phone
801-708-6800
Address
10897 SOUTH RIVER FRONT PARKWAY, #300, SOUTH JORDAN
Compare HCAT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
HCAT
Health Catalyst Inc
|
3.23 | 230.83M | 299.48M | -86.45M | -17.32M | -1.50 |
|
VEEV
Veeva Systems Inc
|
291.20 | 46.72B | 2.97B | 809.93M | 1.33B | 4.8743 |
|
TEM
Tempus Ai Inc
|
89.85 | 14.99B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
66.00 | 12.33B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
94.58 | 8.01B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
35.85 | 7.09B | 906.14M | -52.62M | 89.62M | -0.3621 |
Health Catalyst Inc Stock (HCAT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-27-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Aug-11-25 | Downgrade | Citigroup | Buy → Neutral |
| Aug-08-25 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jun-17-25 | Downgrade | BTIG Research | Buy → Neutral |
| Apr-09-25 | Downgrade | Evercore ISI | Outperform → In-line |
| Jan-08-25 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Apr-10-24 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Jan-03-24 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-13-23 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-13-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Aug-01-23 | Initiated | Cantor Fitzgerald | Overweight |
| May-10-23 | Downgrade | Guggenheim | Buy → Neutral |
| May-10-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Apr-20-23 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Apr-12-23 | Initiated | Stephens | Equal-Weight |
| Apr-04-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-03-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Oct-31-22 | Initiated | Wells Fargo | Equal Weight |
| Oct-25-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-13-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Aug-05-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Aug-05-22 | Downgrade | Stifel | Buy → Hold |
| Apr-14-22 | Initiated | Guggenheim | Buy |
| Mar-17-22 | Upgrade | Jefferies | Hold → Buy |
| Feb-11-22 | Initiated | Goldman | Buy |
| Dec-02-21 | Initiated | Jefferies | Hold |
| Oct-14-21 | Initiated | BTIG Research | Buy |
| Apr-29-21 | Resumed | JP Morgan | Overweight |
| Dec-08-20 | Initiated | Berenberg | Buy |
| Jul-14-20 | Initiated | Citigroup | Buy |
| Jun-18-20 | Initiated | Stifel | Buy |
| Jun-15-20 | Resumed | Evercore ISI | Outperform |
| May-15-20 | Initiated | Guggenheim | Buy |
| Apr-21-20 | Initiated | RBC Capital Mkts | Outperform |
| Apr-13-20 | Initiated | SVB Leerink | Outperform |
| Apr-02-20 | Initiated | Canaccord Genuity | Buy |
| Dec-20-19 | Initiated | Raymond James | Strong Buy |
| Oct-30-19 | Initiated | Cantor Fitzgerald | Overweight |
| Aug-19-19 | Initiated | Evercore ISI | Outperform |
| Aug-19-19 | Initiated | Goldman | Buy |
| Aug-19-19 | Initiated | JP Morgan | Overweight |
| Aug-19-19 | Initiated | Piper Jaffray | Overweight |
| Aug-19-19 | Initiated | SVB Leerink | Outperform |
| Aug-19-19 | Initiated | SunTrust | Buy |
| Aug-19-19 | Initiated | William Blair | Outperform |
View All
Health Catalyst Inc Stock (HCAT) Latest News
Why Health Catalyst Inc. stock could benefit from AI revolution2025 Dividend Review & Growth-Oriented Investment Plans - newser.com
Is Health Catalyst Inc. still worth holding after the dip2025 Big Picture & Advanced Swing Trade Entry Plans - newser.com
Live market analysis of Health Catalyst Inc.Weekly Investment Report & AI Based Buy and Sell Signals - newser.com
Understanding Health Catalyst Inc.’s price movement2025 Trade Ideas & Consistent Growth Equity Picks - newser.com
Building trade automation scripts for Health Catalyst Inc.2025 Fundamental Recap & High Accuracy Investment Signals - newser.com
Is Health Catalyst Inc. stock affected by interest rate hikesWeekly Trend Summary & Long-Term Capital Growth Ideas - newser.com
Quantitative breakdown of Health Catalyst Inc. recent moveGold Moves & Risk Managed Investment Signals - newser.com
Is Health Catalyst Inc. (2YP) stock worth holding before Fed meetingFed Meeting & Technical Confirmation Alerts - newser.com
Will Health Catalyst Inc. stock gain from lower inflation2025 Big Picture & Long-Term Capital Growth Ideas - newser.com
Will Health Catalyst Inc. (2YP) stock hit Wall Street targets2025 Buyback Activity & Expert Approved Trade Ideas - newser.com
Will earnings trigger a reversal in Health Catalyst Inc.Wall Street Watch & Free Community Supported Trade Ideas - newser.com
AMH Equity Ltd Purchases 174,649 Shares of Health Catalyst, Inc. $HCAT - MarketBeat
What does recent volatility data suggest for Health Catalyst Inc.July 2025 Fed Impact & Fast Gain Swing Trade Alerts - newser.com
Can Health Catalyst Inc. stock beat market expectations this quarterWeekly Profit Summary & AI Powered Trade Plan Recommendations - newser.com
Backtesting results for Health Catalyst Inc. trading strategies2025 Dividend Review & Short-Term High Return Ideas - newser.com
Is Health Catalyst Inc. (2YP) stock vulnerable to rate hikes2025 Trade Ideas & Stepwise Trade Signal Implementation - newser.com
Will Health Catalyst Inc. stock benefit from green energy trends2025 EndofYear Setup & Daily Risk Controlled Trade Plans - newser.com
Health Catalyst Inc. stock trend outlook and recovery pathJuly 2025 Trade Ideas & Proven Capital Preservation Methods - newser.com
How to build a dashboard for Health Catalyst Inc. stockGlobal Markets & Real-Time Stock Entry Alerts - newser.com
What indicators show strength in Health Catalyst Inc.July 2025 Spike Watch & Real-Time Volume Spike Alerts - newser.com
Can machine learning forecast Health Catalyst Inc. recoveryQuarterly Earnings Summary & Weekly Sector Rotation Insights - newser.com
Health Catalyst Inc Stock Analysis and ForecastSell Signals and Alerts & Low Risk Investment Plans - earlytimes.in
Health Catalyst Inc Stock (HCAT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):